Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment
Recruiting
Phase 2
Phase 3
Interventional Study
Erosive Oral Lichen Planus
Atrophic Lichen Planus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 35 – 60
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 56 (estimated)
- Sponsor
- Dar Al Uloom University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to assess Honey in orabase (1:1) for treating patients with OLP and improving their quality of life:
The research question aims to answer:
Does honey in orabase (1:1) improve or reduce OLP symptoms compared to the standardized treatment by triamcinolone acetonide 0.1% drug and improve the patient's quality of life?
Participants will:
Take drug ABC or a placeb…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with a clinical diagnosis of oral lichen planus
* Symptomatic OLP lesions (erosive/atrophic)
* Participants are between 35 and 60 years old, who are able to adhere to the study protocol, and sign informed consent.
Exclusion Criteria:
* Patients with other oral mucos…
Contacts